Lot No. LOT-2674 · offered November 18, 2026

Crop EconomicsLot sheet

NGO Court Victory on Golden Rice Costs Philippine Farmers

A 2024 court ruling stopped Golden Rice in the Philippines while 13.9% of preschool children remain vitamin A deficient, and researchers put the stakes in yields, pesticide costs and $2.3 billion.

Market notes

  • Philippine Court of Appeals revoked Golden Rice's commercial propagation permit in April 2024; a USDA report dated 3 November 2026 says restrictions remain while the Supreme Court reviews the case.
  • 2023 National Nutrition Survey, reported in March 2026, found 13.9% of Filipino preschool children were vitamin A deficient.
  • 2014 meta-analysis of 147 studies found GM crop adoption raised yields 22%, cut chemical pesticide use 37% and lifted farmer profits 68%; IFPRI found Bt brinjal in Bangladesh delivered 42% higher net yields and 47% lower pesticide application costs.
  • Ghana's GM cowpea case was dismissed in May 2024 after nine years of proceedings, and insect-resistant Songotra-T was commercialized; Kenya's National Biosafety Authority reported in April 2026 that court cases still hinder commercialization.
  • A 2024 Canadian study found 52% of breeders saw UPOV 1991 as an incentive for breeding investment, and a Vietnam impact assessment estimated more than US$2.3 billion in agricultural income gains.
When NGOs Block Agricultural Innovation, Farmers Pay the Price
PlateWhen NGOs Block Agricultural Innovation, Farmers Pay the Price — chienba / pixabay

The Philippine Court of Appeals revoked Golden Rice's commercial propagation permit in April 2024, and those restrictions remain in force. A USDA report dated 3 November 2026 says the ban continues while the Philippine Supreme Court reviews the case.

That leaves a measurable gap. The Philippine Rice Research Institute estimates one cup of cooked Golden Rice provides about 30% to 50% of a preschool child's estimated average daily vitamin A requirement. The 2023 National Nutrition Survey, reported in March 2026, found 13.9% of Filipino preschool children deficient in vitamin A — roughly one in seven — in a country where rice is the staple.

A column published in Seed World Europe on 18 November 2026 argues that delays of this kind carry a price for growers. Its author, who counts decades in the seed sector, asks plainly: "a victory for whom?" The people celebrating, he writes, are seldom the smallholders losing crops to pests, poor harvests or inadequate nutrition.

What do the field studies actually show?

A 2014 meta-analysis covering 147 studies of genetically modified crops found adoption raised yields by an average of 22%, cut chemical pesticide use by 37% and lifted farmer profits by 68%. The gains ran larger in developing countries, where modest productivity improvements weigh heavily in household income.

A study of Bt cotton adoption among Indian smallholders found higher incomes improved household calorie consumption and dietary quality, reducing food insecurity among the cotton-producing households examined.

In Bangladesh, an independent evaluation by the International Food Policy Research Institute of Bt brinjal found 42% higher net yields, a 39% reduction in the quantity of pesticides used and a 47% cut in pesticide application costs. Those margins matter most to farmers working narrow ones.

Not every technology delivers comparable returns. Results differ by crop, trait and farming conditions, and the meta-analysis now stands more than a decade old. Even so, the numbers above come from harvested fields rather than projections.

Why vitamin A deficiency drives the Golden Rice fight

Vitamin A deficiency ranks among the leading causes of preventable childhood blindness. Early-stage deficiency brings night blindness; severe deficiency causes irreversible eye damage and permanent loss of sight. It also weakens the immune system, raising children's vulnerability to potentially fatal infection.

Scale matters. The World Health Organization has long cited global estimates of 250,000 to 500,000 children going blind each year from vitamin A deficiency, with roughly half dying within a year of losing their sight. Those are historical global estimates, not a current annual count for Southeast Asia.

The Philippine data are more recent. The 2023 National Nutrition Survey, reported in March 2026, put deficiency at 13.9% of preschool children. Not every deficient child will go blind, but the share remains large.

Golden Rice was built for that gap. Polished rice supplies energy but little vitamin A; Golden Rice carries beta carotene, which the body converts into vitamin A. A human study published in 2009 demonstrated that conversion works. The variety was never meant to replace dietary diversification, supplementation or fortification, only to complement them through a food millions of families already eat daily.

Who blocked it, and what did the halt cost?

Regulators authorized Golden Rice as food in 2019 and for commercial propagation in 2021 after extensive safety assessments, and the crop was cultivated and distributed on a pilot scale. In April 2024, litigation initiated by MASIPAG and other opponents of GM crops produced the Court of Appeals decision revoking the propagation permit, with the court citing concerns over environmental safeguards and regulatory compliance.

Greenpeace Southeast Asia, which supported the campaign, called the ruling a "monumental win." The column finds that framing hard to square with children who remain short of vitamin A: "Winning a court case is not the same as feeding a family."

The Philippines is not an isolated case. NGO campaigns have stalled agricultural biotechnology elsewhere:

  • Philippines (Golden Rice, Bt eggplant): litigation by MASIPAG and other opponents halted activities involving these crops in 2024 despite earlier regulatory approvals; Greenpeace publicly welcomed the outcome.
  • India (Bt brinjal): NGO opposition and public campaigns contributed to the government's 2010 moratorium on Bt brinjal, despite a favorable recommendation from its scientific expert committee.
  • Ghana (GM cowpea): Food Sovereignty Ghana and other organizations litigated over GM crop introduction; the case was dismissed in May 2024 after nine years of proceedings, and Ghana commercialized insect-resistant cowpea, Songotra-T, which farmers now report as beneficial.
  • Kenya (GM maize and cassava): litigation involving the Kenya Peasants League challenged the lifting of restrictions; a March 2025 court injunction delayed progress again, and the National Biosafety Authority reported in April 2026 that continuing court proceedings are hindering commercialization of approved technologies.

Does stronger plant variety protection pay for itself?

Opposition reaches beyond biotechnology. In June 2025, a coalition of African and European NGOs campaigned against provisions requiring several African countries to adopt UPOV 1991, arguing that stronger plant variety protection could undermine traditional farming practices.

The counterweight comes from two studies. A 2024 Canadian study found 52% of surveyed breeders consider the strengthened legislation an incentive for greater breeding investment, and a Vietnam impact assessment estimated more than US$2.3 billion in agricultural income gains associated with plant breeding after UPOV membership. PVP is not the sole explanation for those gains, but little of the public debate addresses the varieties, investment and opportunities farmers may never receive.

The author concedes that legal circumstances differ and that not every delay can be attributed exclusively to NGOs; government decisions, regulatory shortcomings and political considerations also create obstacles. Where campaigns succeed, he argues, they should publish what farmers forfeit — additional seasons of crop loss, forgone income and alternatives that could deliver comparable benefits.

Who answers for the farmers on the losing side?

National regulators assess individual products, and cultivation approvals also address environmental considerations. The FAO/WHO Codex Alimentarius Commission adopted internationally recognized principles for GM food safety assessments more than two decades ago, and those procedures exist to judge whether an innovation carries acceptable risk. NGOs retain the right to challenge decisions where credible evidence of harm exists. What the column says they should also do is substantiate the cost of their own campaigns the way developers substantiate safety and benefit claims.

The stakes are not abstract in countries where malnutrition and food insecurity remain threats to survival. The question, the column concludes, is not whether NGOs may oppose innovation. It is whether they will acknowledge and take responsibility for foreseeable consequences when their campaigns succeed.

With the Supreme Court still reviewing the Golden Rice case and Kenya's National Biosafety Authority reporting in April 2026 that court proceedings continue to hold up approved technologies, the next test is whether deployment speeds up.

via seedworld.com (Source)

Filed under

  • golden-rice
  • genetically-modified-crops
  • philippines
  • vitamin-a-deficiency
  • plant-variety-protection
Share this article:

More from Grace Kim

Grace Kim

Show full bio

Correspondent covering people, launches and day-to-day practice in Agribusiness coverage for industry professionals at Agribusiness Wire.

549 articles

Also in the yard

« Previous articleNext article »